Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians Journal Article


Authors: Park, J. Y.; Muscat, J. E.; Kaur, T.; Schantz, S. P.; Stern, J. C.; Richie, J. P.; Lazarus, P.
Article Title: Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians
Abstract: Two members of the mu class of glutathione S-transferase (GST) genes, GSTM1 and GSTM3, have polymorphic alleles which have been associated with altered levels of GST mu protein expression and may be linked to increased risk for several tobacco-related cancers. Oral cancer is a tobacco-related disease that affects African-American men at a significantly higher incidence than Caucasian men. To examine the potential role of GSTM polymorphisms in risk for oral cancer in African-Americans and Caucasians, the prevalences of the GSTM1 null and GSTM3 intron 6 polymorphisms were examined in 63 African-American and 101 Caucasian patients with histologically confirmed primary oral cancer, as well as in 133 African-American and 213 Caucasian matched control subjects. In African-Americans, the odds ratio for oral cancer associated with the GSTM1 (0/0) genotype was 3.1 [95% confidence interval (CI) = 1.1-8.5], with the association between the GSTM1 (0/0) genotype and oral cancer risk strongest in heavy smokers [i.e. > 24 pack-years; odds ratio (OR) = 5.4, 95% CI = 1.2-24]. Using the potentially most protective GSTM1 [+]/GSTIM3 (B/B) genotype as the reference group, increased risk for oral cancer was observed in African-Americans with the GSTM1 [+]/GSTM3 [(A/A)+(A/B)] (OR=2.2, 95% CI = 0.82-6.0), GSTM1 (0/0)/GSTM3 (B/B) (OR = 4.3, 95% CI = 1.1-16), and GSTM1 (0/0)/GSTM3 [(A/A) + (A/B)] (OR = 6.6, 95% CI = 1.2-38) genotypes (P < 0.01, trend test). No significant associations were observed between GSTM genotype and oral cancer risk in Caucasians, These results suggest that the GSTM1 null and GSTM3 intron 6 polymorphisms play an important role in risk for oral cancer among African-Americans and implicates the mu class of GSTs as important tobacco carcinogen detoxifying enzymes in this population. Pharmacogenetics 10:123-131 (C) 2000 Lippincott Williams & Wilkins.
Keywords: smoking; oral cancer; expression; susceptibility; lung-cancer; bladder-cancer; glutathione-s-transferase; gstm1; glutathione s-transferase mu; gstm3; japanese smokers; null genotype; m1 gstm1; cytochrome-p450
Journal Title: Pharmacogenetics
Volume: 10
Issue: 2
ISSN: 0960-314X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2000-03-01
Start Page: 123
End Page: 131
Language: English
ACCESSION: WOS:000086148500004
DOI: 10.1097/00008571-200003000-00004
PROVIDER: wos
PUBMED: 10762000
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stimson P Schantz
    115 Schantz